BRPI0416702A2 - Formulação purgativa colônica, kit, métodos de purgar o cólon de um paciente, de tratar um paciente com, ou suscetível a, um distúrbio gastrointestinal, e de tratar um paciente sofrendo de, ou suscetível à, constipação, e, processo de produzir a formulação purgativa colônica - Google Patents

Formulação purgativa colônica, kit, métodos de purgar o cólon de um paciente, de tratar um paciente com, ou suscetível a, um distúrbio gastrointestinal, e de tratar um paciente sofrendo de, ou suscetível à, constipação, e, processo de produzir a formulação purgativa colônica

Info

Publication number
BRPI0416702A2
BRPI0416702A2 BRPI0416702-3A2A BRPI0416702A BRPI0416702A2 BR PI0416702 A2 BRPI0416702 A2 BR PI0416702A2 BR PI0416702 A BRPI0416702 A BR PI0416702A BR PI0416702 A2 BRPI0416702 A2 BR PI0416702A2
Authority
BR
Brazil
Prior art keywords
patient
suspectable
treating
colonic
proceduring
Prior art date
Application number
BRPI0416702-3A2A
Other languages
English (en)
Inventor
Stephen Skiendzielewski
Martin Rose
Ngoc Do
Original Assignee
Salix Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34632758&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0416702(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Salix Pharmaceuticals Inc filed Critical Salix Pharmaceuticals Inc
Priority to BR122014001142A priority Critical patent/BR122014001142B8/pt
Publication of BRPI0416702A2 publication Critical patent/BRPI0416702A2/pt
Publication of BRPI0416702A8 publication Critical patent/BRPI0416702A8/pt
Publication of BRPI0416702B1 publication Critical patent/BRPI0416702B1/pt
Publication of BRPI0416702B8 publication Critical patent/BRPI0416702B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
BRPI0416702A 2003-11-19 2004-11-17 formulação purgativa colônica em uma forma de dosagem sólida para administração oral, e, kit BRPI0416702B8 (pt)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BR122014001142A BR122014001142B8 (pt) 2003-11-19 2004-11-17 processo de produzir uma formulação em comprimido purgativa colônica para administração oral

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US52314203P 2003-11-19 2003-11-19
US60/523142 2003-11-19
PCT/US2004/038220 WO2005051361A1 (en) 2003-11-19 2004-11-17 Colonic purgative composition with soluble binding agent

Publications (4)

Publication Number Publication Date
BRPI0416702A2 true BRPI0416702A2 (pt) 2015-01-27
BRPI0416702A8 BRPI0416702A8 (pt) 2020-09-24
BRPI0416702B1 BRPI0416702B1 (pt) 2020-10-20
BRPI0416702B8 BRPI0416702B8 (pt) 2022-08-23

Family

ID=34632758

Family Applications (2)

Application Number Title Priority Date Filing Date
BRPI0416702A BRPI0416702B8 (pt) 2003-11-19 2004-11-17 formulação purgativa colônica em uma forma de dosagem sólida para administração oral, e, kit
BR122014001142A BR122014001142B8 (pt) 2003-11-19 2004-11-17 processo de produzir uma formulação em comprimido purgativa colônica para administração oral

Family Applications After (1)

Application Number Title Priority Date Filing Date
BR122014001142A BR122014001142B8 (pt) 2003-11-19 2004-11-17 processo de produzir uma formulação em comprimido purgativa colônica para administração oral

Country Status (12)

Country Link
US (3) US7687075B2 (pt)
EP (2) EP1682098B1 (pt)
JP (3) JP5329042B2 (pt)
KR (4) KR101323628B1 (pt)
CN (2) CN102648980B (pt)
AR (1) AR046651A1 (pt)
AU (2) AU2004292428B2 (pt)
BR (2) BRPI0416702B8 (pt)
CA (2) CA2814523C (pt)
ES (1) ES2584866T3 (pt)
PL (1) PL1682098T3 (pt)
WO (1) WO2005051361A1 (pt)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0224909D0 (en) * 2002-10-25 2002-12-04 Norgine Europe Bv Colon cleansing compositions
US7687075B2 (en) 2003-11-19 2010-03-30 Salix Pharmaceuticals, Ltd. Colonic purgative composition with soluble binding agent
GB0409104D0 (en) * 2004-04-23 2004-05-26 Norgine Europe Bv Compressed pharmaceutical compositions
AU2005320935B2 (en) * 2004-12-30 2012-02-16 Given Imaging Ltd. Device, system and method for in-vivo examination
CA2607250C (en) * 2005-05-06 2012-11-06 Salix Pharmaceuticals, Inc. Polyethylene glycol colonic purgative composition
AU2013202513B2 (en) * 2005-05-06 2016-03-24 Salix Pharmaceuticals, Inc. Polyethylene glycol colonic purgative composition
CN1748675A (zh) * 2005-07-11 2006-03-22 丛晓东 大黄酸类化合物的复合物及制备方法与治疗糖尿病的应用
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
CA2635310C (en) * 2006-04-07 2013-05-14 Sunten Phytotech Co., Ltd. Anthracenedione compounds
DE102006017672B4 (de) * 2006-04-12 2008-07-03 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung zur Verwendung als Laxativum
ES2292345B1 (es) * 2006-05-12 2009-02-16 Madaus, S.A. "uso, composicion y preparacion farmaceutica de plantago ovata".
DE102007023397B4 (de) * 2007-05-02 2015-03-26 Madaus Gmbh Neue pharmazeutische Zusammensetzung zur Verwendung als Laxativum
AU2008254999A1 (en) * 2007-05-17 2008-11-27 Theravance, Inc. Prokinetic agent for bowel preparation
WO2008141368A1 (en) * 2007-05-17 2008-11-27 David Lubowski Combination laxative compositions comprising a colonic stimulant and a bulking laxative
CN101450049A (zh) * 2007-12-07 2009-06-10 辉凌国际制药（瑞士）有限公司 药物组合物
WO2009137672A1 (en) * 2008-05-07 2009-11-12 Salix Pharmaceuticals, Ltd. Methods of treating bowel disease by administering a bowel cleanser and an antibiotic
WO2010005965A1 (en) * 2008-07-08 2010-01-14 Aronchick Craig A Colonic purgative formulations and methods of using the same
KR101053731B1 (ko) * 2008-10-21 2011-08-02 이문성 용해시간 조절형 장세척제 조성물의 제조방법
US20100178360A1 (en) * 2009-01-13 2010-07-15 Universite Libre De Bruxelles Nutritive composition
CN102481316A (zh) * 2009-03-27 2012-05-30 萨利克斯药品有限公司 用于肠道制剂的组合物及其使用方法
PL2421373T3 (pl) * 2009-04-21 2020-03-31 Dale R. Bachwich Układ do płukania okrężnicy
CN101874796A (zh) * 2009-04-29 2010-11-03 田普森 一种治疗便秘的药物制剂及其制备方法
EP2438077B1 (en) * 2009-06-03 2013-12-04 Aptalis Pharma U.S. Inc. L-sugar colon cleansing agent and uses thereof
WO2010144865A2 (en) 2009-06-12 2010-12-16 Meritage Pharma, Inc. Methods for treating gastrointestinal disorders
US20110021591A1 (en) * 2009-07-21 2011-01-27 Gordon Douglas J Phenylbutazone carrier formulation showing increased bioactivity in animals
ES2436850T3 (es) 2009-08-31 2014-01-07 Zeria Pharmaceutical Co., Ltd. Comprimido para administración oral para lavado intestinal
US9040095B2 (en) * 2009-10-14 2015-05-26 Gi Innovations, Pllc Colon cleansing of residual stool and secretions during colonoscopy
US8772242B2 (en) * 2009-10-26 2014-07-08 Thomas Julius Borody Therapy for enteric infections
CN102283861A (zh) * 2010-06-17 2011-12-21 杭州赛利药物研究所有限公司 氢氧化镁在制药中的用途以及氢氧化镁制剂和制备方法
AU2011342368B2 (en) * 2010-12-13 2016-11-17 Rite-Prep Pty Ltd Gastric and colonic formulations and methods for making and using them
MX346936B (es) 2011-01-28 2017-04-05 A Shaver William Metodo, composiciones y empaque para limpieza del intestino.
TWI535461B (zh) 2011-03-11 2016-06-01 諾金私人有限公司 結腸清潔溶液、用於製備該溶液之組成物、包含該組成物或溶液之套組、與製備該溶液之方法
US8778907B2 (en) 2011-04-27 2014-07-15 Cumberland Pharmaceuticals Lactulose for bowel evacuation
CN102178694B (zh) * 2011-05-06 2013-03-20 四川健能制药有限公司 磷酸钠盐液体制剂
JP5842521B2 (ja) * 2011-09-30 2016-01-13 ゼリア新薬工業株式会社 便秘改善薬
RU2640920C2 (ru) * 2011-10-27 2018-01-12 Саликс Фармасьютикалз, ИНК. Электролитные слабительные средства
RU2473330C1 (ru) * 2011-12-09 2013-01-27 Александр Павлович Погромов Средство для кишечного лаважа
PT2877163T (pt) 2012-07-27 2019-05-24 Redhill Biopharma Ltd Formulações e métodos de fabrico de formulações para utilização na evacuação colónica
PL3473248T3 (pl) 2012-09-11 2022-07-25 Norgine Bv Kompozycje zawierające glikol polietylenowy i siarczany metali alkalicznych lub metali ziem alkalicznych do zastosowania jako kompozycje do oczyszczania jelita grubego
WO2014144407A1 (en) 2013-03-15 2014-09-18 Braintree Laboratories, Inc. Dual use oral pharmaceutical composition tablets of sulfate saltes and methods of use thereof
JP2014224080A (ja) * 2013-05-17 2014-12-04 協和化学工業株式会社 大腸の検査または手術のための処置剤
CN103585173B (zh) * 2013-10-28 2016-06-29 王显著 含硫酸钠和匹可硫酸的药物组合物
KR101659746B1 (ko) 2014-01-28 2016-09-26 주식회사한국파마 황산염을 함유하는 장관 하제 조성물 및 이의 제조 방법
CA2947434A1 (en) 2014-04-29 2015-11-05 Colonaryconcepts Llc Foods, systems, methods, and kits for providing electrolyte replacement
WO2016140981A1 (en) 2015-03-02 2016-09-09 Colonaryconcepts Llc Compounds and methods for peg metabolite and peg breakdown product assays
JP6501923B2 (ja) * 2015-06-22 2019-04-17 シーティーシー バイオ インコーポレイテッド 腸管洗浄用の下剤組成物
WO2017011430A1 (en) * 2015-07-13 2017-01-19 Halow George M Bowel cleansing compositions and methods
WO2017131461A1 (ko) * 2016-01-28 2017-08-03 주식회사 씨티씨바이오 하제 조성물
JP2018131396A (ja) * 2017-02-14 2018-08-23 学校法人自治医科大学 経口腸管洗浄剤および大腸カプセル内視鏡用ブースター
US10143656B1 (en) 2017-08-04 2018-12-04 Braintree Laboratories, Inc. Solid oral sulfate salt formulations for cleaning a colon and methods of using same
KR102005072B1 (ko) * 2017-12-15 2019-07-29 주식회사 씨티씨바이오 장관 세척용 하제 조성물
KR102111094B1 (ko) 2018-06-18 2020-05-14 주식회사 한국팜비오 무수황산나트륨, 황산칼륨, 무수황산마그네슘 및 시메티콘을 포함하는 장관하제 경구투여용 고형제제 조성물
CN112386577B (zh) * 2019-08-16 2024-01-23 北京天衡药物研究院有限公司 一种治疗便秘的组合物
CN112587498A (zh) * 2020-12-29 2021-04-02 哈尔滨瀚钧现代制药有限公司 多库酯钠丹蒽醌及其制备方法
CN115040512B (zh) * 2022-07-28 2023-06-20 苏州中化药品工业有限公司 一种药物组合物及其制备方法
WO2024149252A1 (zh) * 2023-01-09 2024-07-18 上海石趣医药科技有限公司 磷酸镁物质、包含其的药物组合物及其用途
WO2024256873A1 (en) 2023-06-15 2024-12-19 Sebela Ireland Limited Methods of administering safe colon cleansing compositions

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3121663A (en) * 1956-02-09 1964-02-18 Plough Lab Inc Carbon dioxide releasing laxative suppository
US3202578A (en) * 1957-09-27 1965-08-24 Elder Paul B Co Polymeric laxative composition and method of using same
GB1459488A (en) * 1974-03-19 1976-12-22 Wyeth John & Brother Ltd Piperazinedione derivatives
US4321263A (en) * 1980-09-30 1982-03-23 Rowell Laboratories, Inc. Psyllium compositions
US4812311A (en) * 1984-12-21 1989-03-14 The Procter & Gamble Company Kit for use in the treatment of osteoporosis
WO1987000754A1 (en) 1985-08-01 1987-02-12 Braintree Laboratories, Inc. Low-sodium laxative and lavage formulation
US4849227A (en) * 1986-03-21 1989-07-18 Eurasiam Laboratories, Inc. Pharmaceutical compositions
US4828842A (en) * 1986-09-16 1989-05-09 L. Perrigo Company Water dispersible compound
US4999200A (en) * 1987-12-09 1991-03-12 Marion Laboratories Psyllium tablet composition, method of manufacture and method of use
JPH0816061B2 (ja) * 1988-07-13 1996-02-21 森下ルセル株式会社 腸管洗浄液用組成物と腸管洗浄液
US5294451A (en) * 1991-03-29 1994-03-15 Curtice-Burns, Inc. Fat substitute compositions having reduced laxative effects
WO1997041838A1 (en) * 1996-05-08 1997-11-13 Aronchick Craig A Non-aqueous colonic purgative formulations
US5397573A (en) * 1993-06-04 1995-03-14 The Procter & Gamble Company Laxative compositions
US5516524A (en) * 1993-12-20 1996-05-14 The Procter & Gamble Company Laxative compositions containing bulk fiber
US5498425A (en) * 1995-03-17 1996-03-12 Block Drug Company, Inc. Phosphosoda buffered saline laxative
US5710183A (en) * 1995-07-14 1998-01-20 Halow; George M. Laxative/antidiarrheal composition comprising polyethylene glycol and fiber bulking agent
FR2746643B1 (fr) * 1996-04-01 1998-06-12 Techni Pharma Nouvelles compositions laxatives et leur procede de fabrication
AU731016B2 (en) * 1996-11-13 2001-03-22 C.B. Fleet Company Incorporated A coated sodium phosphate bowel cleanser
US6162464A (en) 1997-03-31 2000-12-19 Inkine Pharmaceutical, Inc. Non-aqueous colonic purgative formulations
US6048901A (en) * 1999-04-20 2000-04-11 Braintree Laboratories, Inc. Method of reducing intestinal gas, cramping and anorectal irritation
US6264981B1 (en) * 1999-10-27 2001-07-24 Anesta Corporation Oral transmucosal drug dosage using solid solution
US6645481B1 (en) 2000-09-28 2003-11-11 Braintree Laboratories, Inc. Method of achieving overnight laxation and control of bowel function
US6946149B2 (en) 2002-04-30 2005-09-20 Braintree Laboratories, Inc. Salt solution for colon cleansing
US8361452B2 (en) 2002-07-15 2013-01-29 Halow George M Bowel cleansing composition
US20040071779A1 (en) 2002-10-09 2004-04-15 Keiser Dale Arthur Gelled laxative compositions
US7687075B2 (en) 2003-11-19 2010-03-30 Salix Pharmaceuticals, Ltd. Colonic purgative composition with soluble binding agent

Also Published As

Publication number Publication date
BRPI0416702A8 (pt) 2020-09-24
US7687075B2 (en) 2010-03-30
PL1682098T3 (pl) 2016-11-30
WO2005051361A1 (en) 2005-06-09
CN101087593A (zh) 2007-12-12
BRPI0416702B8 (pt) 2022-08-23
BR122014001142B8 (pt) 2021-05-25
EP1682098A1 (en) 2006-07-26
EP1682098B1 (en) 2016-05-25
JP5502807B2 (ja) 2014-05-28
AU2011202346A1 (en) 2011-06-16
US20050129781A1 (en) 2005-06-16
AU2004292428B2 (en) 2011-06-02
BR122014001142B1 (pt) 2018-10-30
BRPI0416702B1 (pt) 2020-10-20
ES2584866T3 (es) 2016-09-29
US7718197B2 (en) 2010-05-18
AR046651A1 (es) 2005-12-14
CN102648980B (zh) 2016-08-31
KR101268559B1 (ko) 2013-05-31
US8507009B2 (en) 2013-08-13
CA2814523A1 (en) 2005-06-09
JP2014065746A (ja) 2014-04-17
CN102648980A (zh) 2012-08-29
JP5329042B2 (ja) 2013-10-30
EP2308476A1 (en) 2011-04-13
CA2546637A1 (en) 2005-06-09
CA2546637C (en) 2013-06-18
US20080213393A1 (en) 2008-09-04
KR20110098015A (ko) 2011-08-31
AU2011202346B2 (en) 2012-05-24
BR122014001142A2 (pt) 2015-08-18
JP2007512336A (ja) 2007-05-17
KR20120045015A (ko) 2012-05-08
AU2004292428A1 (en) 2005-06-09
JP2011173933A (ja) 2011-09-08
CN101087593B (zh) 2013-07-17
KR101323628B1 (ko) 2013-11-01
KR101495690B1 (ko) 2015-02-25
KR20130048790A (ko) 2013-05-10
KR20060114342A (ko) 2006-11-06
CA2814523C (en) 2016-01-12
US20100159026A1 (en) 2010-06-24
EP2308476B1 (en) 2016-12-14

Similar Documents

Publication Publication Date Title
BRPI0416702A2 (pt) Formulação purgativa colônica, kit, métodos de purgar o cólon de um paciente, de tratar um paciente com, ou suscetível a, um distúrbio gastrointestinal, e de tratar um paciente sofrendo de, ou suscetível à, constipação, e, processo de produzir a formulação purgativa colônica
NO20054640D0 (no) Fremgangsmater for behandling av Parkinsons sykdom
DK1443955T3 (da) PDGF-BB til behandling af Parkinsons sygdom
DE60237823D1 (de) Medizinisches behandlungsinstrument
FR15C0069I2 (fr) Formulation a usage topique d'ivermectine pour le traitement de conditions dermatologiques
EP1929929A4 (en) ENDOSCOPE INTRODUCTION AND ENDOSCOPE
EP1644479A4 (en) FUNCTIONAL SYNTHETIC MOLECULES AND MACROMOLECULES FOR GENERAL FEEDING
EP1601248A4 (en) USE OF CORDIAL BLOOD FOR THE TREATMENT OF SUBJECTS SUFFERING FROM A DISEASE, A SUFFERING OR A DISORDER
EP1589933A4 (en) Compositions and methods for the diagnosis and treatment of tumor
DK1392287T3 (da) Anvendelse af substituerede azetidinonderivater i behandlingen af Alzheimers sygdom
EP1462134A4 (en) ADMINISTRATIVE INSTRUMENT FOR MEDICAL USE
EP1691848A4 (en) TOOLS AND TOOL SETS FOR IMPLEMENTING MINIMALLY INVASIVE PROCESSES AT THE SPINE
EP1553912A4 (en) COMPOSITIONS AND METHODS FOR TUMOR DIAGNOSIS AND TREATMENT
CY1116256T1 (el) Il-17 ανταγωνιστικα αντισωματα
EP1541086A4 (en) APPARATUS FOR RECORDING BIOLOGICAL INFORMATION AND BIOLOGICAL INFORMATION USING THE AUTHORIZATION DEVICE
EP1583750A4 (en) MACROCYCLIC BETA-SEKRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER DISEASE
FR2854074B1 (fr) Utilisation de l'ivermectine pour le traitement de desordres dermatologiques
EP2126566A4 (en) METASTASE-SPECIFIC SPLICE VARIATIONS OF MENA AND APPLICATIONS THEREOF IN THE DIAGNOSIS, FORECAST AND TREATMENT OF TUMORS
EP1636625A4 (en) CONFOCAL MICROSCOPE FOR ILLUSTRATING SELECTED PLACES OF A PATIENT'S BODY
EP1601333A4 (en) NEW INTRODUCTION STATIONS IN POCKET VECTORS
PT1411064E (pt) ''anticorpos recombinantes associados a gangliósidos e sua utilização no diagnóstico e tratamento de tumores''
DK1623228T3 (da) Aopciii og behandling og diagnose af diabetes
EE200300216A (et) Radiofarmatseutilised ained Alzheimeri tõve diagnoosimiseks
EE200100179A (et) Farmatseutilised agendid Parkinsoni tõve, ADHD jamikroadenoomide raviks
EP1590041A4 (en) TREATMENT OF DENTISTRY DISEASE WITH PHOTOSENSIBILIZERS

Legal Events

Date Code Title Description
B11Z Dismissal: petition dismissal - article 216, par 2 of industrial property law

Free format text: REFERENTE A PETICAO 020060070989/RJ DE 18/05/2006.

B12F Other appeals [chapter 12.6 patent gazette]
B11M Decision cancelled [chapter 11.13 patent gazette]

Free format text: EM ATENDIMENTO A DECISAO RECURSAL PUBLICADA NA RPI 2229, FOI REFORMADO O ARQUIVAMENTO DA PETICAO NO 020060070989 DE 18/05/2006.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B25C Requirement related to requested transfer of rights

Owner name: SALIX PHARMACEUTICALS, INC. (US)

Free format text: A FIM DE ATENDER A TRANSFERENCIA, REQUERIDA ATRAVES DA PETICAO NO 20060106934 DE 17/07/2006, E NECESSARIO APRESENTAR O DOCUMENTO DEVIDAMENTE NOTARIZADO E COM APOSTILAMENTO OU LEGALIZACAO CONSULAR, TRADUCAO JURAMENTADA DO MESMO, ALEM DA GUIA DE CUMPRIMENTO DE EXIGENCIA.

B25B Requested transfer of rights rejected

Owner name: SALIX PHARMACEUTICALS, INC. (US)

Free format text: INDEFERIDO O PEDIDO DE TRANSFERENCIA CONTIDO NA PETICAO 20060106934 DE 17/07/2006, POR AUSENCIA DE CUMPRIMENTO DA EXIGENCIA PUBLICADA NA RPI NO 2512, DE 26/02/2019.

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 20/10/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 17/11/2004 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B15V Prolongation of time limit allowed
B25A Requested transfer of rights approved

Owner name: SALIX PHARMACEUTICALS, INC. (US)

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 20A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2801 DE 10-09-2024 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.